Navigating Access & Policy Barriers for the Next Generation of Cell & Gene Therapies
- Addressing access obstacles and new considerations in emerging indications to expand CAR‑T cell therapy and gene therapy delivery beyond oncology and smaller indications
- Policy challenges and opportunities to broaden treatment reach across the US outside major academic centres and improving patient access pathways
- Identifying key areas of reimbursement and access policy shaping that will enable future patients to receive innovative therapies